XENE

Xenon Pharmaceuticals
XENE

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$2.49B
EV
$1.80B
Shares Outstanding
79.47M
Beta
1.11

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$55.23
P/E 2025E
-
P/Revenue 2025E
299.87x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Xenon Pharmaceuticals Inc.

gainify
XENE

Xenon Pharmaceuticals Inc.

XENE

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN1101, a novel and potent Kv7 potassium chann...

Sector

Healthcare

Industry

Biotechnology

CEO

Mortimer, Ian

Employees

322

IPO Date

2014-11-05

Headquarters

3650 Gilmore Way, Suite 200, Burnaby, British Columbia, V5G 4W8, Canada

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.